883554-88-9

Basic information

• Product Name: tert-butyl 4-carbamoylpiperazine-1-carboxylate
• Synonyms: tert-Butyl 4-carbamoylpiperazine-1-carboxylate
• CAS NO: 883554-88-9
• Molecular Formula: C₁₀H₁₉N₃O₃
• Molecular Weight: 229.2762
• Mol File: 883554-88-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 346°C at 760 mmHg
• Flash Point: 163°C
• Density: 1.18g/cm³
• Vapor Pressure: 5.95E-05mmHg at 25°C
• Refractive Index: 1.514
• Storage Temp.: 2-8°C(protect from light)
• PKA: 14.67±0.20(Predicted)
• CAS DataBase Reference: tert-butyl 4-carbamoylpiperazine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-carbamoylpiperazine-1-carboxylate(883554-88-9)
• EPA Substance Registry System: tert-butyl 4-carbamoylpiperazine-1-carboxylate(883554-88-9)

Safety Data

• Hazardous Substances Data: 883554-88-9(Hazardous Substances Data)

Upstream product

• 590-28-3 potassium cyanate 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 64-19-7 acetic acid 
• 1118-02-1 trimethylsilyl isocyanate 

Downstream Products

• 118753-66-5 4-Amino-piperazine-1-carboxylic acid tert-butyl ester 
• 474711-89-2 piperazine-1-carboxamide hydrochloride 

Relevant articles and documents

OXAZOLIDINE-BASED COMPOUND AND SELECTIVE ANDROGEN RECEPTOR AGONIST COMPRISING SAME

Provided are novel selective androgen receptor agonists, a preparation method thereof, and a pharmaceutical composition including the same at a pharmaceutically effective amount. The selective androgen receptor agonists according to the present invention

Aromatic heterocyclic derivatives and applications of aromatic heterocyclic derivatives in medicines

The present invention discloses aromatic heterocyclic derivatives and applications of the aromatic heterocyclic derivatives in medicines, and specifically provides a class of aromatic heterocyclic compounds or stereoisomers, geometric isomers, tautomers, racemic bodies, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof, and pharmaceutical compositions containing the compounds. The present invention further discloses uses of the compounds or pharmaceutical compositions in drug preparation, wherein the drug is used for treatment of respiratory diseases, particularly chronic obstructive pulmonary disease (COPD).

3-HYDRAZONE PIPERAZINYL RIFAMYCIN DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS

The present invention is directed to novel 3-hydrazone piperazinyl rifamycin derivatives, pharmaceutical compositions containing them and the use of said derivatives and pharmaceutical compositions as antimicrobial agents against pathogenic microorganisms, particularly against resistant microbes.